Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Chatal

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
Annales D'Endocrinologie|January 1, 1988
[Treatment of malignant pheochromocytoma by 131-I-metaiodobenzylguanidine]B Charbonnel, J F Chatal, A J Brendel, et al.
European Journal of Cancer|February 1, 1981
Use of serial carcinoembryonic antigen assays in detecting relapses in breast cancer involving high risk of metastasisJ F Chatal, F Chupin, G Ricolleau, et al.
European Journal of Nuclear Medicine|January 1, 1989
Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodiesA Chetanneau, P A Lehur, D Ripoche, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
International Journal of Cancer|September 17, 1996
Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniquesA Devys, P Thedrez, E Gautherot, et al.
Hybridoma|July 1, 1986
Comparative characteristics of 17-1A and GA-733 monoclonal antibodies for immunoscintigraphic applicationJ F Chatal, P Thedrez, H Blottière, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9C Curtet, C Tellier, J Bohy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1993
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimerP Peltier, C Curtet, J F Chatal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
Evaluation of indium-111-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic diseaseP De Faucal, P Peltier, B Planchon, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
Annales D'Endocrinologie|January 1, 1988
[Treatment of malignant pheochromocytoma by 131-I-metaiodobenzylguanidine]B Charbonnel, J F Chatal, A J Brendel, et al.
European Journal of Cancer|February 1, 1981
Use of serial carcinoembryonic antigen assays in detecting relapses in breast cancer involving high risk of metastasisJ F Chatal, F Chupin, G Ricolleau, et al.
European Journal of Nuclear Medicine|January 1, 1989
Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodiesA Chetanneau, P A Lehur, D Ripoche, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
International Journal of Cancer|September 17, 1996
Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniquesA Devys, P Thedrez, E Gautherot, et al.
Hybridoma|July 1, 1986
Comparative characteristics of 17-1A and GA-733 monoclonal antibodies for immunoscintigraphic applicationJ F Chatal, P Thedrez, H Blottière, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9C Curtet, C Tellier, J Bohy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1993
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimerP Peltier, C Curtet, J F Chatal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
Evaluation of indium-111-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic diseaseP De Faucal, P Peltier, B Planchon, et al.
Pageof 15